International Standard ISO 10993-7 | |
Biological evaluation of medical devices Part 7: Ethylene oxide sterilization residuals Évaluation biologique des dispositifs médicaux — Partie 7: Résidus de stérilisation à l'oxyde d'éthylène Reference number ISO 10993-7:2026(en) | Third edition 2026-04
© ISO 2026
|
[1] | ISO 11135:2014, Sterilization of health-care products — Ethylene oxide — Requirements for the development, validation and routine control of a sterilization process for medical devices | |
[2] | Association for the Advancement of Medical Instrumentation, Good Hospital Practice: Ethylene Oxide Gas — Ventilation Recommendations and Safe Use, Arlington, VA, 1987 | |
[3] | Abdel‑Rahman, M.S. and Kadry, A.M. Studies on the use of uncertainty factors in deriving RfDs, Hum. Ecolog. Risk Assess., 1, pp. 614‑624, 1995 | |
[4] | Abdel‑Rahman, S.Z., El‑Zein, R.A., Ammenheuse, M.M., Yang, Z., Stock, T.H., Morandi, M. and Ward, J.B. Jr. Variability in human sensitivity to 1,3‑butadiene: Influence of the allelic variants of the microsomal epoxide hydrolase gene, Environ. Mol. Mutagen., 41(2), pp. 140‑6 | |
[5] | Abrahams R.H. Recent studies with workers exposed to ethylene oxide, in: Jorkasky J.F., ed., Safe use of ethylene oxide, Proceedings of the Educational Seminar, Washington DC, Health Industries Manufacturers Association, 27‑38, pp. 211‑220, HIMA Report No. 80‑4, 1980 | |
[6] | Adams, C.H., Werely, C.J., Victor, T.C., Hoal, E.G., Rossouw, G., van Helden, P.D. Allele frequencies for glutathione S‑transferase and N‑acetyltransferase 2 differ in African population groups and may be associated with oesophageal cancer or tuberculosis incidence, Clin. Chem. Lab. Med. 41(4), pp. 600‑605, 2003 | |
[7] | Adler, N. Residual ethylene oxide and ethylene glycol in ethylene oxide sterilized pharmaceuticals, J. Pharm. Sci. 1965; 54(5), pp. 735‑742 | |
[8] | Alleva, F. (Cited in Balazs[18], 1976) | |
[9] | Alomar, A., Camarasa, J.M. and Noguera, J.E.A. Ethylene oxide dermatitis, Contact Dermatitis, 7, pp. 205‑207, 1981 | |
[10] | AMBROSE, A. Toxicological studies of compounds investigated for use as inhibitors of biological processes. II Toxicity of ethylene chlorohydrin. Arch. Ind. Hyg. Occup. Med. 1950; 2:582‑597. | |
[11] | Anand, V.P., Cogdill, C.P., Klausner, K.A., Lister, L., Barbolt, T., Page, B.F.J., Urbanski, P., Woss Casimir, J., Boyce, J.Reevaluation of ethylene oxide hemolysis and irritation potential, J. Biomed. Mater. Res. 64A, pp. 648‑654, 2003 | |
[12] | Andersen, S. Ethylene oxide toxicity, J. Lab. Clin. Med., 77(2), pp. 346‑356, 1971 | |
[13] | AAMI ST29-1988, Recommended practice for determining residual ethylene oxide in medical devices, Association for the Advancement of Medical Instrumentation, American National Standard. Arlington, VA, AAMI, 1988 | |
[14] | AAMI ST30-1989, Determining residual ethylene chlorohydrin and ethylene glycol in medical devices, Association for the Advancement of Medical Instrumentation, American National Standard. Arlington VA, AAMI, 1989 | |
[15] | ASTM E691-18, Standard practice for conducting an interlaboratory study to determine the precision of a test method | |
[16] | ATSDR Tp‑90‑16:1990, Toxicological profile for ethylene oxide. Atlanta, GA, US Department of Health and Human Services, Public Health Service | |
[17] | ATSDR. Toxicological profile for ethylene glycol and propylene glycol. Atlanta, GA, 2010 | |
[18] | Balazs, T. Toxicity of ethylene oxide and chloroethanol, FDA By‑lines No. 3, pp. 150‑155, 1976 | |
[19] | Ball, N.A. Determination of ethylene chlorohydrin and ethylene glycol in aqueous solutions and ethylene oxide in associated plastics, J. Pharm. Sci., 73(9), pp. 1305‑1307, 1984 | |
[20] | Bartels, M.J. Comparison of in vitro metabolism of ethylene glycol in rat and human liver S‑9 homogenate, Midland MI, R&D Report of the Dow Chemical Company, 2001 | |
[21] | Basketter, D.A., Griffiths, H.A., Wang, X.M., Wilhelm, K.P. and McFadden, J. Individual, ethnic and seasonal variability in irritant susceptibility of the skin: the implications for a predictive human patch test, Contact Dermatitis, 35(4), pp. 208‑213, 1996 | |
[22] | Beliles, R.P., Parker, J.C. Risk assessment and oncodynamics of ethylene oxide as related to occupational exposure, Toxicol Ind Health 3(3), pp. 371‑82, 1987 | |
[23] | Bjorge, C., Brunborg, G., Wiger, R., Holme, J.A., Scholz, T., Dybing, E. and Soderlund, E.J. A comparative study of chemically induced DNA damage in isolated human and rat testicular cells, Reprod Toxicol. 10(6), pp. 509‑519, 1996 | |
[24] | Blood, F. Chronic toxicity of ethylene glycol in the rat, Fd. Cosmet. Tox., 3, pp. 229‑234, 1965 | |
[25] | Blood, F., Elliott, G. and Wright, M. Chronic toxicity of ethylene glycol in the monkey, Tox. Appl. Pharm. 4, pp. 489‑491, 1962 | |
[26] | Bommer, J. and Ritz, E. Ethylene oxide as a major cause of anaphylactoid reactions in dialysis (a review). Artif. Organs, 11, pp. 111‑117, 1987 | |
[27] | Bousquet, J. and Michel, F.B. Allergy to formaldehyde and ethylene‑oxide, Clin. Rev. Allergy 9, pp. 357‑370, 1991 | |
[28] | Brobst, K.M. and Han, T. Determination of chlorohydrins in hydroxypropyl starch ethers, J. Assoc. Off. Anal. Chem., 54(5), pp. 1093‑1094, 1971 | |
[29] | Brown, D.J. Determination of ethylene oxide and ethylene chlorohydrin in plastic and rubber surgical equipment sterilized with ethylene oxide, J. Assoc. Off. Anal. Chem., 53(2), pp. 263‑267, 1970 | |
[30] | Bruch, C.W. Industrial Sterilization, eds. Phillips, G.B., Miller, W.S., Duke University Press, Durham, NC, pp. 49‑77, 1973 | |
[31] | BUA, Ethylene oxide, German Chemical Society (GDCh) Advisory Committee on Existing Chemicals of Environmental Relevance (Beratergremium für Umweltrelevante Altstoffe). Stuttgart, Hirzel Verlag (BUA Report 141), 1995 | |
[32] | Buehler, B.A., Rao, V., Finnell, R.H. Biochemical and molecular teratology of fetal hydantoin syndrome, Neurol Clin., 12(4), pp. 741‑748, 1994 | |
[33] | Carpenter, C., Smyth, H. and Pozzani, U. The assay of acute vapor toxicity, and the grading and interpretation of results on 96 chemical compounds, J. Ind. Hyg. Toxicol. 31, pp. 343‑349, 1949 (cited in EPA, 1985) | |
[34] | Center for Drug Evaluation and Research (CDER), Review Guidance, Validation of Chromatographic Methods, November 1994 | |
[35] | Chesler, S.N., Rebbert, R.E. and Enagonio, D.P. Evaluation of AAMI EO residues recommended practice and a determination of EO kinetics in water, National Bureau of Standards, Department of Commerce, Washington, DC, October 1985 | |
[36] | Choi, S. and Kim, S. Lipopolysaccharide inhibition of rat hepatic microsomal epoxide hydrolase and glutathione S‑transferase gene expression irrespective of nuclear factor‑kappaB activation, Biochem. Pharmacol., 56(11), pp. 1427‑1436, 1988 | |
[37] | Conine, D., Naumann, B. and Hecker, L. Setting health‑based residue limits for contaminants in pharmaceuticals and medical devices, Quality Assurance: Good Practice, Regulation, and Law, 1, pp. 171‑180, 1992 | |
[38] | Courtney, K., Andrews, J. and Grady, M. Teratogenic evaluation of ethylene chlorohydrin (Ech, 2‑chloroethanol) in mice, J. Environ. Sci. Health, B17(4), pp. 381‑391, 1982 | |
[39] | Cyr, W.H., Glaser, Z.R. and Jacobs, M.E. CDRH risk assessment of EO residues on sterilized medical devices, in: Jorkasky, J.; ed. Sterilization in the 1990s (Health Industry Manufacturers Association Report No. HIMA 89‑1). Washington, DC: HIMA, pp. 269‑285, 1989 | |
[40] | Danielson, J.W., Snell, R.P. and Oxborrow, G.S. Detection and quantitation of ethylene oxide, 2‑chloroethanol, and ethylene glycol with capillary gas chromatography, J. Chromatogr., 28, pp. 97‑101, 1990 | |
[41] | Depass, L., Garman, R., Woodside, M., Giddens, W., Maronpot, R. and Weil, C. Chronic toxicity and carcinogenicity studies of ethylene glycol in rats and mice, Fund. Appl. Tox., 7, pp. 547‑565, 1986 | |
[42] | Depass, L., Woodside, M., Maronpot, R. and Weil, C. (1986b) Three‑generation reproduction and dominant lethal mutagenesis studies of ethylene glycol in the rat, Fund. Appl. Tox., 7, pp. 566‑572, 1986 | |
[43] | Dunkelberg, H. Carcinogenicity of ethylene oxide and 1,2‑propylene oxide upon intragastric administration to rats, Br. J. Cancer, 46, pp. 924‑933, 1982 | |
[44] | Edelhauser, H., Antoine, M., Pederson, H., Hiddeman, J. and Harris, R. Intraocular safety evaluation of ethylene oxide and sterilant residues, J. Toxicol. Cut. Ocular Toxicol., 2, pp. 7‑39, 1983 | |
[45] | Ehrenberg, L., Tornqvist, M. The research background for risk assessment of ethylene oxide: aspects of dose, Mutat. Res., 330(1‑2), pp. 41‑54, 1995 | |
[46] | Ethylene Oxide Residues on Sterilized Medical Devices, Environ Corporation, Washington, DC, 1987 (also in: Health Industry Manufacturers Association, HIMA Report 88‑6. Washington, DC, 1988) | |
[47] | Ettre, LS. and Jones, E. Quantitative analysis with headspace gas chromatography using multiple headspace extraction, Chromatography Newsletter, 12(1), July 1984 | |
[48] | Evans, A.J., Henner, W.D., Eilers, K.M., Montalto, M.A., Wersinger, E.M., Andersen, P.E., Cohen, J.I., Everts, E.C., McWilliams, J.E. and Beer, T.M. Polymorphisms of GSTT1 and related genes in head and neck cancer risk. Head Neck, 26(1), pp. 63‑70, 2004 | |
[49] | Falzon, M., Milton, A.S., Burke, M.D. Are the decreases in hepatic cytochrome P‑450 and other drug‑metabolising enzymes caused by indomethacin in vivo mediated by intestinal bacterial endotoxins? 16,16‑Dimethylprostaglandin F2 alpha prevents decreases in hepatic drug‑metabolising enzymes due to exogenous endotoxin, Biochem. Pharmacol., 33(8), pp. 1285‑1292, April 15, 1984 | |
[50] | Fennell, T.R., MacNeela, J.P., Morris, R.W., Watson, M., Thompson, C.L., Bell, D.A. Hemoglobin adducts from acrylonitrile and ethylene oxide in cigarette smokers: effects of glutathione S‑transferase T1‑null and M1‑null genotypes, Cancer Epidemiol Biomarkers Prev., 9(7), pp. 705‑712, 2000 | |
[51] | Fennell, T.R. and Brown, C.D. A physiologically based pharmacokinetic model for ethylene oxide in mouse, rat, and human, Toxicol. Appl. Pharmacol., 173(3), pp. 161‑75, 2001 | |
[52] | Fisher, J.W., Dorman, D.C., Medinsky, M.A., Welsch, F., Conolly, R.B. Analysis of respiratory exchange of methanol in the lung of the monkey using a physiological model, Toxicol. Sci., 53(2), pp. 185‑193, 2000 | |
[53] | Fost, U., Tornqvist, M., Leutbecher, M., Granath, F., Hallier, E., Ehrenberg, L. Effects of variation in detoxification rate on dose monitoring through adducts, Hum. Exp. Toxicol., 14(2), pp. 201‑3, 1995 | |
[54] | Fuchs, J., Wullenweber, U., Hengstler, J.G., Bienfait, H.G., Hiltl, G., Oesch, F. Genotoxic risk for humans due to work place exposure to ethylene oxide: remarkable individual differences in susceptibility, Arch Toxicol., 68(6), pp. 343‑8, 1994 | |
[55] | Gaunt, J., Hardy, J., Gangolli, S., Butterworth, K. and Lloyd, A. Bibra, 14, p. 109, 1975 (cited in Rowe and Wolf, 1982 and Environ, 1987) | |
[56] | Gaylor, D.W. Quantitative Cancer Risk Assessment for Exposure to Ethylene Oxide from Medical Devices, submitted to the CDRH Toxicology Risk Assessment Committee, June 29, 1993 | |
[57] | Glaser, Z.R. Ethylene oxide: Toxicology review and field study results of hospital use, J. Environ. Path. Tox., 2, pp. 173‑208, 1979 | |
[58] | Golberg, L. Hazard Assessment of Ethylene Oxide, CRC Press, Boca Raton, FL, 1986 | |
[59] | Goldblatt, M.W. Brit. J. Ind. Med., 1, p. 213, 1944 | |
[60] | Griffeth, L.K., Rosen, G.M. and Rauchman, E.J. Effects of model traumatic injury on hepatic drug metabolism in the rat. VI. Major detoxification/toxification pathways, Drug Metab. Dispos., 15(6), pp. 749‑59, 1987 | |
[61] | Guess, W. Tissue reactions to 2‑chloroethanol in rabbits, Tox. Appl. Pharm., 16, pp. 382‑390, 1970 | |
[62] | Guidelines for data acquisition and data quality evaluation in environmental chemistry. Anal. Chem., 52(14), 1980 | |
[63] | Hackett P., Brown R., Buschboom R., Clark M., Miller R., Music R. et al. Teratogenic Study of Ethylene Oxide and Propylene Oxide and n‑Butyl Acetate (NIOSH Contract No. 210‑80‑0013), Battelle Pacific Northwest Laboratories, Richland, WA, 1982 (cited in EPA, 1985) | |
[64] | Hallier, E., Langhof, T., Dannappel, D., Leutbecher, M., Schroder, K., Goergens, H.W., Muller, A. and Bolt, H.M. Polymorphism of glutathione conjugation of methyl bromide, ethylene oxide and dichloromethane in human blood: influence on the induction of sister chromatid exchanges (SCE) in lymphocytes, Arch. Toxicol., 67(3), pp. 173‑178, 1993 | |
[65] | Handlos, V. Determination of gas residuals in ethylene oxide sterilized materials — A literature survey. Archiv. Pharm. Chemi. Sci., 4, pp. 73‑80, 1976 | |
[66] | Handlos, V. The hazards of ethylene oxide sterilization. Arch. Pharm. Chemi. Sci., 7, pp. 939‑949, 1979 | |
[67] | Hanzlik, P., Seidenfeld, M. and Johnson, C. General properties, irritant and toxic actions of ethylene glycol, J. Pharm. Exp. Ther., 41(4) pp. 387‑406, 1931 | |
[68] | Hartman, P.A. and Bowman, P.B. Simple GLC determination of ethylene oxide and its reaction products in drug and formulations, J. Pharm. Sci., 66(6), pp. 789‑792, 1977 | |
[69] | Hassett, C., Lin, J., Carty, C.L., Laurenzana, E.M. and Omiecinski, C.J. Human hepatic microsomal epoxide hydrolase: comparative analysis of polymorphic expression, Arch. Biochem. Biophys., 337(2), pp. 275‑283, 1997 | |
[70] | Health Industry Manufacturers Association. Guidelines for the Analysis of Ethylene Oxide Residues in Medical Devices (HIMA Document No. 1, Vol. 2). Washington, DC: HIMA, 1980 | |
[71] | Hogstedt, C., Rohlen, O., Berndtsson, B.S., Axelson, O. and Ehrenberg, L. A cohort study of mortality and cancer incidence in ethylene oxide production workers, Br. J. Ind. Med., 36(4), pp. 276‑80, 1979 | |
[72] | Hollingsworth, R., Rowe, V., Oyen, F., McCallister, D. and Spencer, H. Toxicity of ethylene oxide determined on experimental animals. AMA Arch. Ind. Health., 13, pp. 217‑227, 1956 | |
[73] | Hu, J.J., Mohrenweiser, H.W., Bell, D.A., Leadon, S.A. and Miller, M.S. Symposium overview: genetic polymorphisms in DNA repair and cancer risk, Toxicol. Appl. Pharmacol., 185(1), pp. 64‑73, 2002 | |
[74] | Hubaux, A. and Gilbert, V. Decision and detection limits for linear calibration curves,Anal. Chem., 42(8), pp. 849‑855, 1970 | |
[75] | International Agency for Research on Cancer (IARC) (1994) Some industrial chemicals. Ethylene oxide, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 60. IARC, Lyon, pp. 73‑159 | |
[76] | Improved detection and separation of glycols and ethylene oxide residues using GC (Bulletin 789), Supelco, Inc., 1980 | |
[77] | International Conference on Harmonization (ICH). Harmonised Tripartite Guideline; Text on the Validation of Analytical Procedures: Recommended for adoption at step 4 of the ICH process on 27 October 1994 | |
[78] | Jacobson, K., Hackley, E. and Feinsilver, L. The toxicity of inhaled ethylene oxide and propylene oxide vapors, AMA Arch. Ind. Health., 13, pp. 237‑244, 1956 | |
[79] | Japan Association of Disposable Medical Device Industries, Guideline for ethylene oxide sterilization of disposable medical devices (second edition), December 1989 | |
[80] | Johnson, M. Metabolism of chloroethanol in the rat, Biochem. Pharmacol., 16, pp. 185‑199, 1967 | |
[81] | Johnson, M. Detoxication of ethylene chlorohydrin, Fd. Cosmet. Tox., 5, p. 449, 1967 | |
[82] | Jones‑Price C., Kimmel T., Marks T., Ledoux T., Reel J., Fisher P. et al. Teratologic Evaluation of Ethylene Oxide (CAS No. 75‑78‑8) in New Zealand White Rabbits (Final report RB80‑EO, NIEHS Contract No. 1‑ES‑2127). Research Triangle Park, NC, National Institute of Environmental Health Sciences, 1982 (cited in EPA, 1985) | |
[83] | Jones‑Price, C., Marks, T., Ledoux, T., Reel, J., Fischer, P., Langhoff‑Paschke, L., Marr, M. and Kimmel, C. Teratologic Evaluation of Ethylene Chlorohydrin (CAS No. 107‑07‑3) in New Zealand White Rabbits (PB85‑170959). Research Triangle Park, NC, National Institute of Environmental Health Sciences, 1985a | |
[84] | Jones‑Price, C., Marks, T., Ledoux, T., Reel, J., Fischer, P., Langhoff‑Paschke, L., Marr, M. and Kimmel, C. Teratologic Evaluation of Ethylene Chlorohydrin (CAS No. 107‑07‑3) in CD‑1 mice (PB85‑172104). Research Triangle Park, NC, National Institute of Environmental Health Sciences, 1985b | |
[85] | Karel, L., Landing, B. and Harvey, T. The intraperitoneal toxicity of some glycols, glycol ethers, glycol esters and phthalates in mice.Fed. Proceedings, 1947; 6:342 | |
[86] | Kashtock, M. Use of specific retention volumes in evaluation of various types of columns for use in the trace determination of ethylene glycol by gas chromatography, J. Chromatogr., 176, pp. 25‑35, 1979 | |
[87] | Kaye, M.M. and Nevell, T.G. Statistical evaluation of methods using headspace gas chromatography for the determination of ethylene oxide. Analyst., 110, pp. 1067‑1071, 1985 | |
[88] | Kerr, B.M., Rettie, A.E., Eddy, A.C., Loiseau, P., Guyot, M., Wilensky, A.J., Levy, R.H. Inhibition of human liver microsomal epoxide hydrolase by valproate and valpromide: in vitro/in vivo correlation, Clin. Pharmacol. Ther., 46(1), pp. 82‑93, 1989 | |
[89] | Kikuchi, H., Nakamura, A. and Tsuji, K. Gas chromatographic determination with electron capture detection of residual ethylene oxide in intraocular lenses, J. Assoc. Off. Anal. Chem., 71, pp. 1057‑1062, 1988 | |
[90] | Kitteringham, N.R., Davis, C., Howard, N., Pirmohamed, M., Park, B.K. Interindividual and interspecies variation in hepatic microsomal epoxide hydrolase activity: studies with cis‑stilbene oxide, carbamazepine 10, 11‑epoxide and naphthalene, J. Pharmacol. Exp. Ther., 278(3), pp. 1018‑1027 | |
[91] | Knudsen, L.E., Loft, S.H., Autrup, H. Risk assessment: the importance of genetic polymorphisms in man, Mutat. Res., 482(1‑2), pp. 83‑88, 2001 | |
[92] | Lucas,AD;StratmeyerME(2008)Extraction of ethylene oxide residue in medical devicesBiomedical Instrumentation and Technology,42:76-795 | |
[93] | Kroetz, D.L., Kerr, B.M., McFarland, L.V., Loiseau, P., Wilensky, A.J. and Levy, R.H. Measurement of in vivo microsomal epoxide hydrolase activity in white subjects, Clin. Pharmacol. Ther., 53(3), pp. 306‑315, March 1993 | |
[94] | Kulkarni, R.K., Bartak, D., Ousterhout, D.K. and Leonard, F. Determination of residual ethylene oxide in catheters by gas‑liquid chromatography, J. Biomed. Mat. Res., 2, pp. 165‑171, 1968 | |
[95] | Laborde, J. and Kimmel, C. The teratogenicity of ethylene oxide administered intravenously to mice. Tox. Appl. Pharm., 56, pp. 16‑22, 1980 | |
[96] | Lakind, J.S., McKenna, E.A., Hubner, R.P. and Tardiff, R.G. A review of the comparative mammalian toxicity of ethylene glycol and propylene glycol, Crit. Rev. Toxicol., 29(4), pp. 331‑365, 1999 | |
[97] | Lamb, J. IV, Maronpot, R., Gulati, D., Russell, V., Hommel‑Barnes, L. and Sabharwal, P. (1985). Reproductive and developmental toxicity of ethylene glycol in the mouse, Tox. Appl. Pharm. 81, pp. 100‑112, 1985 | |
[98] | Landen, W.O., Thompson, D.W. and Floyd, K.M. Determination of ethylene oxide and ethylene glycol in wet surgical dressings, FDA By‑Lines, No. 2, 1971 | |
[99] | Landin, H.H., Golkar, S.O., Zorcec, V., Tornqvist, M. Biomonitoring of Epicholorhydrin by Hemoglobin Adducts, Anal. Biochem., 240, pp. 1‑6, 1996 | |
[100] | Landin, H.H., Grummt, T., Laurent, C. and Tates, A. Monitoring of occupational exposure to epichlorohydrin by genetic effects and hemoglobin adduct, Mut. Res., 381, pp. 217‑226, 1997 | |
[101] | Latven, A. and Molitor, H. Comparison of the toxic, hypnotic and irritating properties of eight organic solvents, J. Pharm. Exp. Ther., 65, pp. 89‑94, 1939 | |
[102] | Lawrence, W., Turner, J. and Autian, J. Toxicity of ethylene chlorohydrin I: Acute toxicity studies, J. Pharm. Sci., 60(4), pp. 568‑571, 1971 | |
[103] | Lawrence, W., Itoh, K., Turner, J. and Autian, J. Toxicity of ethylene chlorohydrin II: Subchronic toxicity and special tests, J. Pharm. Sci., 60(8), pp. 1163‑1168, 1971 | |
[104] | Lawrence, W., Dillingham, E., Turner, J. and Autian, J. Toxicity profile of chloroacetaldehyde, J. Pharm. Sci., 61(1), pp. 19‑25, 1972 | |
[105] | Lee, HT., Daniel, A. and Walker, C. Conformance test procedures (CTP) for verifying the labelling claims for precision, bias, and interferences in in‑vitro diagnostic devices used for the quantitative measurement of analytes in human body fluids, in Bureau of Medical Devices Biometrics Report 8202, Food and Drug Administration, Silver Spring, MD, April 1982 | |
[106] | Long, G.L. and Winefordner, J.D. Limit of detection — A closer look at the IUPAC definition, Anal. Chem., 55(7), pp. 712A‑724A, 1983 | |
[107] | Lynch, D., Lewis, T., Moorman, W., Sabharwal, P. and Burg, J. Toxic and mutagenic effects of ethylene oxide and propylene oxide on spermatogenic functions in Cynomolgus monkeys, Toxicologist., 3, p. 60, 1982 | |
[108] | Lynch, D., Lewis, T., Moorman, W., Burg, J., Groth, D., Khan, A., Ackerman, L. and Cockerell, B. Carcinogenic and toxicologic effects of inhaled ethylene oxide and propylene oxide in F 344 rats, Tox. Appl. Pharm., 76, pp. 69‑84, 1984 | |
[109] | Lynch D., Lewis T., Moorman W. et al. Effects on monkeys and rats of long‑term inhalation exposure to ethylene oxide: Major findings of the NIOSH study, in In-hospital ethylene sterilization, Current issues in ET0 toxicity and occupational exposure, AAMI Technology Assessment Report No. 8‑84, Association for the Advancement of Medical Instrumentation, Arlington, VA, pp. 7‑10, 1984 | |
[110] | Malanoski, A.J. Analyst performance standards: Determination for and from collaborative studies, J. Assoc. Off. Anal. Chem., 65(6), pp. 1333‑1338, 1982 | |
[111] | Manius, G.J. Determination of ethylene oxide, ethylene chlorohydrin, and ethylene glycol residues in ophthalmic solution at proposed concentration limits, J. Pharm. Sci., 68(12), pp. 1547‑1549, 1979 | |
[112] | Marlowe, D.E., Lao, N.T., Lao, C.S., Eaton, A.R. and Page, B.F.J. Interlaboratory Comparison of Ethylene Oxide Residue Analysis Test Methods (HHS Publication FDA 86‑4204), March 1986 | |
[113] | Marlowe D.E. Summary of results from interlaboratory comparison of ethylene oxide residue analysis test methods, Paper presented at AAMI Conference on In‑hospital EO sterilization, Arlington, VA, November 1983 | |
[114] | Marlowe, D.E., Lao, N.T., Eaton, A.R., Page, B.F.J. and Lao, C.S. An interlaboratory comparison of analytical methods for ethylene oxide, J. Pharm. Sci., 76, pp. 333‑337, 1986 | |
[115] | Maronpot, R., Zelenak, J., Weaver, E. and Smith, N. Teratogenicity study of ethylene glycol in rats, Drug Chem. Tox., 6(6), pp. 579‑594, 1983 | |
[116] | Mason, M., Cate, C. and Baker, J. Toxicology and carcinogenesis of various chemicals used in the preparation of vaccines, Clin. Toxicol., 4(2):185‑204, 1971 | |
[117] | Matsumoto, T., Hardaway, R.M., Pani, K.C., Sater, C.M., Bartak, D.E. and Margetis, P.M. Safe standard of aeration for ethylene oxide sterilized supplies, Arch. Surg., 96, pp. 464‑470, 1968 | |
[118] | McDonald, T., Roberts, M. and Borgmann, A. Ocular toxicity of ethylene chlorohydrin and ethylene glycol in rabbit eyes, Tox. Appl. Pharm., 21, pp. 143‑150, 1972 | |
[119] | McDonald, T., Kasten, K., Hervey, R., Gregg, S., Borgmann, A. and Murcheson, T. Acute ocular toxicity of ethylene oxide, ethylene glycol and ethylene chlorohydrin, Bull. Parent. Drug Assoc., 27(4), pp. 153‑164, 1973 | |
[120] | McDonald, T., Kasten, K., Hervey, R., Gregg, S. and Button, B. Acute ocular toxicity for normal and irritated rabbit eyes and subacute ocular toxicity for ethylene oxide, ethylene chlorohydrin and ethylene glycol, Bull. Parent. Drug Assoc., 31(1), pp. 25‑32, 1977 | |
[121] | McGlynn, K.A., Hunter, K., Levoyer, T., Roush, J., Wise, P., Michielli, R.A., Shen, F.M., Evans, A.A., London, W.T., Buetow, K.H. Susceptibility to a flatoxin B1‑related primary hepatocellular carcinoma in mice and humans, Cancer Res., 63(15), pp. 4594‑4601, 2003 | |
[122] | Melnick, R. (1984). Toxicities of ethylene glycol and ethylene glycol monoethyl ether in Fischer 344/N rats and B6C3F1 mice, Env. Hlth. Perspect., 57, pp. 147‑155, 1984 | |
[123] | Mertes, I., Fleischmann, R., Glatt, H.R. and Oesch, F. Interindividual variations in the activities of cytosolic and microsomal epoxide hydrolase in human liver, Carcinogenesis, 6(2) pp. 219‑223, February 1985 | |
[124] | Millar, M.R., Sharpe, R.M., Weinbauer, G.F., Fraser, H.M., Saunders, P.T. Marmoset spermatogenesis: organizational similarities to the human, Int. J. Androl., 23(5) pp. 266‑77, October 2000 | |
[125] | Mogenhan, J.A., Whitbourne, J.E. and Ernst, R.R. Determination of ethylene oxide in surgical materials by vacuum extraction and gas chromatography, J. Pharm. Sci., 60(2), pp. 222‑224, 1971 | |
[126] | Moore, J.A., Daston, G.P., Faustman, E., Golub, M.S., Hart, W.L., Hughes, C. Jr, Kimmel, C.A., Lamb, J.C., Schwetz, B.A. and Scialli, A.R. An evaluative process for assessing human reproductive and developmental toxicity of agents, Reprod. Toxicol., 9(1), pp. 61‑95, 1995 | |
[127] | Mordenti, J. Man versus beast: pharmacokinetic scaling in mammals, J. Pharm. Sci., 75(11), pp. 1028‑1040, 1986 | |
[128] | Mori, K., Kaido, M., Fujishiro, K., Inoue, N., Koide, O., Hori, H. and Tanaka, I. Dose dependent effects of inhaled ethylene oxide on spermatogenesis in rats, Br. J. Ind. Med., 48(4), pp. 270‑274, April 1991 | |
[129] | Morris, T., Nelson, M. and Calvery, A. Observations on the chronic toxicities of propylene glycol, ethylene glycol, diethylene glycol, ethylene glycol mono‑ethyl‑ether, and diethylene glycol mono‑methyl‑ether, J. Pharm. Exp. Ther., 74, pp. 266‑273, 1942 | |
[130] | Muller, M., Kramer, A., Angerer, J. and Hallier, E. Ethylene oxide‑protein adduct formation in humans: influence of glutathione‑S‑transferase polymorphisms, Int. Arch. Occup. Environ. Health., 71(7), pp. 499‑502, 1998 | |
[131] | Muzeni, R.J. Rapid gas chromatographic determination of ethylene oxide, ethylene chlorohydrin, and ethylene glycol residues in rubber catheters, J. Assoc. Off. Anal. Chem., 68(3), pp. 506‑508, 1985 | |
[132] | Nakamura, A., Kikuchi, H. and Tsuji, K. Determination of ethylene oxide residue in commercially available intraocular lenses by new sensitive method (Electron capture detection/gas chromatography), IOL, 3, pp. 4‑8, 1989 | |
[133] | National Toxicology Program (NTP). Toxicology and Carcinogenicity Studies of 2‑Chloroethanol (Ethylene Chlorohydrin) (CAS. No 107‑07‑3) in F344/N Rats and Swiss CD‑1 Mice (Dermal Studies) (NTP TR275, NIH Publication 86‑2531). Research Triangle Park, NC, NTP, 1985 | |
[134] | National Toxicology Program (NTP). Toxicology and Carcinogenicity Studies of Ethylene Oxide (CAS No. 75‑21‑8) in B6C3F1 Mice (Inhalation Studies) (NTP Technical Report 326, U.S. Department of Health and Human Services, Public Health Services, National Institute of Health). Research Triangle Park, NC, NTP, 1987 | |
[135] | National Toxicology Program (NTP). Toxicology and Carcinogenesis Studies of Ethylene Glycol (CAS No. 107‑21‑1) in B6C3F1 mice (feed studies) (NTP Technical Report 413, U.S. Department of Health and Human Services). Research Triangle Park, NC, NTP, 1993 | |
[136] | National Toxicology Program — Center for the Evaluation of Risks to Human Reproduction Expert Panel, Report on the Reproductive and Developmental Toxicity of Ethylene Glycol. NTP‑CERHR‑EG‑03, 2003 | |
[137] | Neeper‑Bradley T. Developmental Toxicity Evaluation of Ethylene Glycol Administrated by Gavage to CD(R) (Sprague‑Dawley) Rats: Determination of a “No Observable Effect Level” (NOEL), Report 52‑656, Bushy Run Research Center, Union Carbide Corporation, Export, PA (Study sponsored by Ethylene Glycol Panel, Chemical Manufacturers Association. Washington, D.C.), 1990 | |
[138] | Nivard, M.J., Czene, K., Segerback, D. and Vogel, E.W. Mutagenic activity of ethylene oxide and propylene oxide under XPG proficient and deficient conditions in relation to N‑7‑(2‑hydroxyalkyl)guanine levels in Drosophila, Mutat. Res., 529(1‑2), pp. 95‑107, 2003 | |
[139] | Northup, S., Weinckowski, D., Martis, L. and Darby, T. Toxicity caused by acute and subacute intravenous administration of ethylene oxide in the rat, J. Environ. Pathol. Toxicol., 5, pp. 617‑623, 1981 | |
[140] | Oba, T., Tsuji, K., Mizumachi, S., Kikuchi, H., Shintani, H., Iida, K. and Meguro, K. Studies on residual ethylene oxide in medical devices (I) — Gas chromatographic determination of ethylene oxide in plastics. Ikakikai‑gaku, 52(3), pp. 134‑139, 1982 | |
[141] | Ohba, T. Safety of residual ethylene oxide and ethylene oxide concentrations in the working environment of sterilization facilities, in Gaughren, E.; Morrissey, R.; You‑sen, W.; eds., Sterilization of Medical Products Volume IV, Polyscience Publications, Montreal, pp. 172‑177, 1986 | |
[142] | Olsen, A.K., Bjortuft, H., Wiger, R., Holme, J., Seeberg, E., Bjoras, M. and Brunborg, G. Highly efficient base excision repair (BER) in human and rat male germ cells, Nucleic Acids Res. 29(8), pp. 1781‑90, 2001 | |
[143] | Omiecinski, C.J., Aicher, L. and Swenson, L. Developmental expression of human microsomal epoxide hydrolase, J. Pharmacol. Exp. Ther. 269(1), pp. 417‑23, 1994 | |
[144] | Omiecinski, C.J., Hassett, C. and Hosagrahara, V. Epoxide hydrolase‑polymorphism and role in toxicology. Toxicol. Lett., 112‑113, pp. 365‑70, 2000 | |
[145] | Oser, B., Morgareidge, K., Cox, G. and Carson, J. Short‑term toxicity of ethylene chlorohydrin (ECH) in rats, dogs and monkeys, Fd. Cosmet. Tox., 13, pp. 313‑315, 1975 | |
[146] | Pharmaceutical Manufacturers Association. Procedures for setting limits for volatile organic solvents with methylene chloride as an example of the process. Committee on Rational Specifications for Impurities in Bulk Drug Substances — Pharmaceutical Manufacturers Association. In: Pharmacopeial Forum. Washington, DC: PMA, 1989; November‑December, pp. 5748‑5759 | |
[147] | Pharmaceutical Manufacturers Association. Application of the PMA procedure for setting residue limits for organic volatile solvents in pharmaceuticals to ethylene oxide. Prepared by D.L. Conine and the PMA subcommittee of Industrial Toxicologists. Procedures for setting limits for organic volatile solvents with chloroform, 1,4‑dioxane, ethylene oxide, and trichloroethylene as examples of the process. Committee on Rational Specifications for Impurities in Bulk Drug Substances — Pharmaceutical Manufacturers Association. In: Pharmacopeial Forum. Washington, DC: PMA, May‑June:557‑572, 1990 | |
[148] | Pottenger, L.H., Carney, E.W. and Bartels, M.J. Dose‑dependent nonlinear pharmacokinetics of ethylene glycol metabolites in pregnant (GD 10) and nonpregnant Sprague‑Dawley rats following oral administration of ethylene glycol, Toxicol. Sci. 62, pp. 10‑19, 2001 | |
[149] | Price, C., Kimmel, C., Tyl, R. and Marr, M. The developmental toxicity of ethylene glycol in rats and mice, Tox. Appl. Pharm., 81, pp. 113‑127, 1985 | |
[150] | Price, C., Tyl, R., Marr, M. and Kimmel, C. Teratologic evaluation of ethylene glycol (EG) in CD rats and CD‑1 mice, Teratology, 29(2): 52A, 1984 | |
[151] | Ragelis, E.P., Fisher, B.S., Kimeck, B.A. and Johnson, C. Isolation and determination of chlorohydrins in foods fumigated with ethylene oxide or propylene oxide. J. Assoc. Off. Anal. Chem., 51(3), pp. 709‑717, 1968 | |
[152] | Roberts, J. and Seibold, H. Ethylene glycol toxicity in the monkey, Tox. Appl. Pharm. 15, pp. 624‑631, 1969 | |
[153] | Robinson, M., Pond, C., Laurie, R., Bercz, J., Henningsen, G. and Condie, L. Subacute and subchronic toxicity of ethylene glycol administered in drinking water to Sprague‑Dawley rats, Drug Chem. Tox., 13(1), pp. 43‑70, 1990 | |
[154] | Rodricks, J.V. and Brown, S.L. Data requirements for assessment of device risks, J. Am. Coll. Toxicol., 7, pp. 509‑518, 1988 | |
[155] | Romano, S.J. and Renner, J.A. Comparison of analytical methods for residual ethylene oxide analysis, J. Pharm. Sci., 64(8), pp. 1412‑1417, 1975 | |
[156] | Romano, S.J., Renner, J.A. and Leitner, P.M. Gas chromatography determination of residual ethylene oxide by head space analysis, Anal. Chem., 45(14), pp. 2327‑2330, 1973 | |
[157] | Romaguera, C. and Vilaplana, J. Airborne occupational contact dermatitis from ethylene oxide, Contact Dermatitis, 39, p. 85, 1997 | |
[158] | Rossini, A., Rapozo, D.C., Amorim, L.M., Macedo, J.M., Medina, R., Neto, J.F., Gallo, C.V. and Pinto, L.F. Frequencies of GSTM1, GSTT1, and GSTP1 polymorphisms in a Brazilian population, Genet. Mol. Res., 1(3), pp. 233‑40, 2002 | |
[159] | Rowe, V. and McCollister, S. Alcohols. Chapter Fifty‑Five, in: Clayton, G., Clayton, F., eds. Patty's Industrial Hygiene and Toxicology (3rd ed. Vol. 2C Toxicology), John Wiley & Sons, New York, pp. 4675‑4684, 1982 | |
[160] | Rowe, V. and Wolf, M. Glycols. Alcohols. Chapter Fifty, in: Clayton, G.; Clayton, F.; eds. Patty's Industrial Hygiene and Toxicology (3rd ed. Vol. 2C Toxicology). John Wiley & Sons, New York, pp. 3817‑3832, 1982 | |
[161] | Registry of Toxic Effects of Chemical Substances (RTECS). 1985‑1986, National Institute for Occupational Safety and Health, DHHS (NIOSH) Publication No. 87‑114, Rockville, MD, pp. 2361‑2362, 1987 | |
[162] | Registry of Toxic Effects of Chemical Substances (RTECS). National Institute for Occupational Safety and Health, On‑line, Rockville, MD, 2006 | |
[163] | Schroder, K.R., Wiebel, F.A., Reich, S., Dannappel, D., Bolt, H.M. and Hallier, E. Glutathione‑S‑transferase (GST) theta polymorphism influences background SCE rate, Arch. Toxicol., 69(7), pp. 505‑507, 1995 | |
[164] | Schuler, R., Hardin, B., Niemeier, R., Booth, G., Hazelden, K., Piccirillo, V. and Smith, K. Results of testing fifteen glycol ethers in a short‑term in vivo reproductive toxicity assay, Env. Hlth. Perspect. 57, pp. 141‑146, 1984 | |
[165] | Segerback, D., Osterman‑Golkar, S., Molholt, B. and Nilsson, R. In vivo tissue dosimetry as a basis for cross‑species extrapolation in cancer risk assessment of propylene oxide, Regul. Toxicol. Pharmacol. 20(1 Pt 1), pp. 1‑14 | |
[166] | Seilken, R. and Valdez‑Flores, C. Cancer Dose‑Response Modeling and Risk Characterizations Based on Animals Exposed to Ethylene Oxide FINAL REPORT, Submitted to Ethylene Oxide Industry Council, 2000 | |
[167] | Shimizu, H., Ohara, K. and Sawa, M. Sterile anterior segment inflammation presumably due to absorbed ethylene oxide to the implanted intraocular lens, Rinsho Ganka (Japanese J. Clin. Ophthalmol.), 40(11), pp. 1219‑1225, 1986 | |
[168] | Shupack, J.L., Andersen, S.R. and Romano, S.J. Human skin reactions to ethylene oxide. J. Lab. Clin. Med., 98, pp. 723‑729, 1981 | |
[169] | Snellings, W.M., Maronpot, R.R., Zelenak, J.P. et al.Teratology study in Fischer 344 rats exposed to ethylene oxide by inhalation, Toxicol. Appl. Pharmacol., 64, 476‑481, 1982 | |
[170] | Snellings, W., Maronpot, R., Zelenak, J. and Laffoon, C. Teratology study in Fischer 344 rats exposed to ethylene oxide by inhalation, Tox. Appl. Pharm., 64, pp. 476‑481, 1982a | |
[171] | Snellings, W., Zelenak, J. and Weil, C. Effects on reproduction in Fischer rats exposed to ethylene oxide by inhalation for one generation, Tox. Appl. Pharm., 63, pp. 382‑388, 1982b | |
[172] | Snellings, W., Weil, C. and Maronpot, R. A subchronic inhalation study on the toxicologic potential of ethylene oxide in B6C3F1 mice, Tox. Appl. Pharm., 76, pp. 510‑518, 1984a | |
[173] | Snellings, W., Weil, C. and Maronpot, R. A two‑year inhalation study of the carcinogenic potential of ethylene oxide in Fischer 344 rats, Tox. Appl. Pharm., 75, pp. 105‑117, 1984b | |
[174] | Snyder, L.R. A rapid approach to selecting the best experimental conditions for high‑speed liquid column chromatography — Part 1 — Estimating initial sample resolution and the final resolution required by a given problem, J. Chromatogr. Sci.; 10, pp. 201‑212, 1972 | |
[175] | Spitz, H.D. and Weinberger, J. Determination of ethylene oxide, ethylene chlorohydrin and ethylene glycol by gas chromatography, J. Pharm. Sci., 60(2), pp. 271‑274, 1971 | |
[176] | Stayner, L., Steenland, K., Greife, A., Hornung, R., Hayes, R.B., Nowlin, S., Morawetz, J., Ringenburg, V., Elliot, L. and Halperin, W. Exposure‑response analysis of cancer mortality in a cohort of workers exposed to ethylene oxide, Am. J. Epidemiol., 138(10), pp. 787‑98, 1993 | |
[177] | Steenland, K., Stayner, L., Greife, A. et al.A cohort mortality study of workers exposed to ethylene oxide, N. Engl. J. Med., 324, pp. 402‑407, 1991 | |
[178] | Steenland, K., Stayner, L. and Deddens, J. Mortality analysis in a cohort of 18235 ethylene oxide exposed workers: follow up extended from 1987 to 1998, Occup. Environ. Med., 61, pp. 2‑7, 2004 | |
[179] | Tanaka, S., Nakaura, S., Kawashima, K., Kasuya, Y. and Omori, Y. Studies on the hemolytic activity and dermal irritability of ethylene oxide and its reaction products. Jap. J. Med. Instrum. 52(1), pp. 21‑28, 1982 | |
[180] | Taylor, J.S. Dermatologic hazards from ethylene oxide, Cutis, 19, pp. 189‑192, 1977 | |
[181] | Teta, M.J., Sielken, R.L. jr.m and Valdez‑Flores, C. Ethylene oxide cancer risk assessment based on epidemiological data: application of revised regulatory guidelines, Risk Anal. 19(6), pp. 1135‑55, 1999 | |
[182] | Thier, R., Lewalter, J., Kempkes, M., Selinski, S., Bruning, T. and Bolt, H.M. Haemoglobin adducts of acrylonitrile and ethylene oxide in acrylonitrile workers, dependent on polymorphisms of the glutathione transferases GSTT1 and GSTM1, Arch. Toxicol., 73(4‑5), pp. 197‑202, 1999 | |
[183] | Thier, R., Bruning, T., Roos, P.H., Rihs, H.P., Golka, K., Ko, Y. and Bolt, H.M. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes, Int. J. Hyg. Environ. Health., 206(3), pp. 149‑71, 2003 | |
[184] | Thier, R., Balkenhol, H., Lewalter, J., Selinski, S., Dommermuth, A. and Bolt, H.M. Influence of polymorphisms of the human glutathione transferases and cytochrome P450 2E1 enzyme on the metabolism and toxicity of ethylene oxide and acrylonitrile, Mutat. Res., 482(1‑2), pp. 41‑46, 2001 | |
[185] | Tyl R. Developmental Toxicity Evaluation of Ethylene Glycol Administrated by Gavage to DC(R)‑1 Mice: Determination of a “No‑Observable‑Effect Level” (NOEL), Report 51‑591, Bushy Run Research Center. Union Carbide Corporation, Export, PA. (Study sponsored by Ethylene Glycol Panel.) Washington, DC, Chemical Manufacturers Association, 1988 | |
[186] | Tyler T.R., McKelvey J.A. Dose dependent disposition of 14C labelled ethylene oxide in rats, Export, PA, Bushy Run Research Center (TSCATS/017061; EPA/OTS Document No. 878212056),1982 | |
[187] | US Environmental Protection Agency. (1985) Health Assessment Document for Ethylene Oxide (EPA 600/8‑84‑009F). Research Triangle Park, NC, EPA, 1985. https://iris.epa.gov/Document/&deid=41115 | |
[188] | US Environmental Protection Agency. (1996) Guidelines for Reproductive Toxicity Risk Assessment EPA/630/R‑96/009. https://www.epa.gov/ncea/raf/pdfs/repro51.pdf | |
[189] | U.S. Food and Drug Administration. EO, ECH & EG, Proposed maximum residue limits and maximum levels of exposure (HEW/FDA), Federal Register. Washington, DC, June 23, 1978; 43(122) | |
[190] | Chromatography U.S.P. (section 621) in: United States Pharmacopeia 29th Edition, United States Pharmacopeial Convention 2006 | |
[191] | USP Validation of Compendial Methods (section 1225) in: United States Pharmacopeia 29th Edition, United States Pharmacopeial Convention 2006 | |
[192] | Vogel, E.W. and Natarajan, A.T. DNA damage and repair in somatic and germ cells in vivo, Mutat. Res., 330(1‑2), pp. 183‑208, 1995 | |
[193] | Warren, B. The determination of residual ethylene oxide and halogenated hydrocarbon propellants in sterilized plastics, J. Pharm. Pharmacol., 23(suppl.), pp. 170S‑175S, 1971 | |
[194] | Weil, C. Statistics vs. safety factors and scientific judgement in the evaluation of safety for man, Tox. Appl. Pharm., 21, pp. 454‑463, 1972 | |
[195] | Weinbauer, G.F., Aslam, H., Krishnamurthy, H., Brinkworth, M.H., Einspanier, A. and Hodges, J.K. Quantitative analysis of spermatogenesis and apoptosis in the common marmoset (Callithrix jacchus) reveals high rates of spermatogonial turnover and high spermatogenic efficiency, Biol. Reprod. 64(1), pp. 120‑126, 2001 | |
[196] | Weinberger, J. GLC Determination of ethylene chlorohydrin following co‑sweep extraction, J. Pharm. Sci., 60(4), pp. 545‑547, 1971 | |
[197] | Wernerman, J., Luo, J.L. and Hammarqvist, F. Glutathione status in critically‑ill patients: possibility of modulation by antioxidants, Proc. Nutr. Soc., 58(3), pp. 677‑680, 1999 | |
[198] | Wesley, F., Rourke, B. and Darbishire, O. The formation of persistent toxic chlorohydrins in foodstuffs by fumigating with ethylene oxide and propylene oxide, J. Food Sci., 30, pp. 1037‑1042, 1965 | |
[199] | Whitbourne, J.E., Mogenhan, J.A. and Ernst, R.R. Determination of 2‑chloroethanol in surgical materials by extraction and gas chromatography, J. Pharm. Sci., 58(3), pp. 1024‑1025, August 1969 | |
[200] | White, J.D. and Bradley, T.J. Residual ethylene oxide in methyl methacrylate polymer powders by GLC, J. Pharm. Sci., 62(10), pp. 1623‑1637, 1973 | |
[201] | World Health Organization (WHO). Ethylene Oxide. Concise International Chemical Assessment Document 54, WHO, Geneva, 2003. https://iris.who.int/bitstream/handle/10665/42639/9241530545.pdf?sequence=1 | |
[202] | Wiencke, J.K., Premble, S., Kettere, B. and Kelsey, K.T. Gene deletion of Glutathione‑S‑transferase theta: correlation with induced genetic damage and potential role in endogenous mutagenesis, Cancer Epidemiol. Biomarkers Prev., 4(3), pp. 253‑259, 1995 | |
[203] | Woodard G., Woodard M. Toxicity of residuals from ethylene oxide gas sterilization. Proceedings of the Health Industry Association Technical Symposium, Washington, DC, pp. 140‑161, 1971 | |
[204] | Yin, L., Liu, C., Shih, L. and Po, K. A study of the teratogenic action of ethylene glycol in rats, Zhonghua Yugangyixue Zazhi, 20(5), 289‑290, 1986 | |
[205] | Yong, L.C., Schulte, P.A., Wiencke, J.K., Boeniger, M.F., Connally, L.B., Walker, J.T., Whelan, E.A. and Ward, E.M. Hemoglobin adducts and sister chromatid exchanges in hospital workers exposed to ethylene oxide: effects of glutathione S‑transferase T1 and M1 genotypes, Cancer Epidemiol. Biomarkers Prev., 10(5), pp. 539‑550, 2001 | |
[206] | Zagar, L.A. Determination of residual ethylene oxide in methyl methacrylate polymer powders by GLC, J. Pharm. Sci., 61(11), pp. 1801‑1803, 1972 | |
[207] | Zheng, W., Wen, W.Q., Gustafson, D.R., Gross, M., Cerhan, J.R. and Folsom, A.R. GSTM1 and GSTT1 polymorphisms and postmenopausal breast cancer risk, Breast Cancer Res. Treat., 74(1), p. 9, 2002 | |
[208] | ICH Q2R1 Validation of Analytical Procedures: Text and Methodology – Nov 2005 | |
[209] | Validation of analytical procedures: Text and methodology Q2 (R1), ICH Harmonised Tripartite Guideline, November 2005 | |
[210] | Harmonized Guidelines for Single Laboratory Validation Methods of Analysis (IUPAC Technical Report). Pure Appl. Chem., Vol. 74, No. 5, pp. 835.855, 2002 | |
[211] | AOAC Guidelines for Single Laboratory Validation of Chemical Methods for Dietary Supplements and Botanicals (December 12, 2002) | |
[212] | Guidance for industry - Analytical Procedures and Methods Validation for Drugs and Biologics, US. Department of Health and Human Services, FDA, July 2015 | |
[213] | Harmonisation of strategies for the validation of quantitative analytical procedures A SFSTP proposal Part I. J. Pharm. Biomed. Anal. 2004, 36 pp. 579–586 | |
[214] | Eurachem, The Fitness for Purpose of Analytical Methods, A Laboratory Guide to Method Validation and Related Topics. Second Edition, 2014 | |
[215] | Gimeno, Auguste, Handlos, Nielsen, Schmidt, Lassu, Vogel, Fischer, Brenier, Duperray, Identification and quantification of ethylene oxide in sterilized medical devices using multiple headspace GC/MS measurement, Journal of Pharmaceutical and Biomedical Analysis, 158 (2018) 119–127 | |
[216] | AD Lucas, C Forrey, D Saylor, K Vorvolakos. Solvent or thermal extraction of ethylene oxide from polymeric materials: Medical device considerations, JBMR 2018:106B, 2455-2463 | |
[217] | Lucas, AD; Merritt, K; Hitchins, V; Woods, T.; McNamee, S; Lyle, DB; Brown, SA. (2003) Residual Ethylene Oxide in Medical Devices and Device Material J. of Biomed. Mat. Res. Appl. Biomat. 66B:548-552 | |
[218] | Handlos V. Kinetics of the aeration of ethylene-oxide sterilized plastics. Biomaterials. 1980 Jul 1;1(3):149–57 | |
[219] | Vink P, Pleijsier K. Aeration of ethylene oxide-sterilized polymers. Biomaterials. 1986 May 1;7(3):225–30 | |
[220] | Grunow, W., Altmann, HJ. Toxicokinetics of chloroethanol in the rat after single oral administration,Arch. Toxicol.,49(3-4), pp. 275-284, 1982 | |
[221] | U.S. Environmental Protection Agency. (2012) Provisional Peer-Reviewed Toxicity Values for 2-Chloroethanol (CASRN 107-07-3) EPA/690/R‑12/007F. https://cfpub.epa.gov/ncea/pprtv/documents/Chloroethanol2.pdf | |
[222] | ISO 10993-4:2017, Biological evaluation of medical devices — Part 4: Selection of tests for interactions with blood | |
[223] | ISO 10993-17:2023, Biological evaluation of medical devices — Part 17: Toxicological risk assessment of medical device constituents | |
[224] | ISO 10993-18:2020, Biological evaluation of medical devices — Part 18: Chemical characterization of medical device materials within a risk management process | |
[225] | ISO 11139:2018, Sterilization of health care products — Vocabulary of terms used in sterilization and related equipment and process standards | |
[226] | ISO 11979-5:2020, Ophthalmic implants — Intraocular lenses — Part 5: Biocompatibility | |
[227] | ISO 14971:2019, Medical devices — Application of risk management to medical devices | |
[228] | Woodman (2005) Ethylene Oxide Residuals Detected on Medical Devices after Processing in the EO Gas 4 Three-hour Exposure Cycle. Andersen Scientific, Inc. Protocol No.: ANSCI081205S4. https://www.sterility.com/wp-content/uploads/PN0000_-092821-EO4-Residuals.pdf | |
[229] | “Metal and glass do not absorb ethylene oxide, but may retain pockets of gas in semi-closed cavities.” GUIDANCE NOTE FOR THE SAFE USE OF ETHYLENE OXIDE IN STERILISATION /FUMIGATION PROCESSES [NOHSC:3016(1992)], Section 1.6, p.48. https://www.safeworkaustralia.gov.au/system/files/documents/1702/guidancenote_safeuseofethyleneoxideinsterilisationfumigationprocesses_nohsc3016-1992_pdf.pdf | |
[230] | American Chemistry Council (ACC). Ethylene Oxide Product Stewardship Guidance Manual. Feb 2 2023, p.15. https://www.americanchemistry.com/industry-groups/ ethylene-oxide/resources/ ethylene-oxide-product-stewardship-manual-2023 | |
[231] | Agency for Toxic Substances and Disease Registry (ATSDR). 2022. Toxicological Profile for Ethylene Oxide. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service | |
[232] | International Agency for Research on Cancer (IARC) (2012) Chemical agents and related occupations, Ethylene oxide. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 100F: A Review of Human Carcinogens. IARC, Lyon, pp 379–400 | |
[233] | Kirman & Hays. Derivation of endogenous equivalent values to support risk assessment and risk management decisions for an endogenous carcinogen: Ethylene oxide, Regulatory Toxicology and Pharmacology, 91, 2017, 165-172. https://doi.org/10.1016/j.yrtph.2017.10.032 | |
[234] | Lynch et al. Systematic review of the scientific evidence on ethylene oxide as a human carcinogen. Chemico-Biological Interactions, Volume 364, 2022, 110031. https://doi.org/10.1016/j.cbi.2022.110031 | |
[235] | Marsh G.M., et al. Ethylene oxide and risk of lympho-hematopoietic cancer and breast cancer: a systematic literature review and meta-analysis. (2019) International Archives of Occupational and Environmental Health, 92 (7), pp. 919 – 939. DOI: 10.1007/s00420-019-01438-z | |
[236] | Mikoczy et al. (2011) Cancer incidence and mortality in Swedish sterilant workers exposed to ethylene oxide: updated cohort study findings 1972-2006. Int J Environ Res Public Health 8:2009–2019. https://doi.org/10.3390/ijerph8062009 | |
[237] | National Toxicology Program (NTP). 2021. Report on Carcinogens, Fifteenth Edition. Research Triangle Park, NC: U.S. Department of Health and Human Services, Public Health Service.3https://doi.org/10.22427/NTP-OTHER-1003 | |
[238] | Scientific Committee on Occupational Exposure Limits (SCOEL). Recommendation from the Scientific Committee on Occupational Exposure Limits for ethylene oxide. European Commission. SCOEL/SUM/160. June 2012 | |
[239] | Sheehan et al. Ethylene Oxide Exposure in U.S. Populations Residing Near Sterilization and Other Industrial Facilities: Context Based on Endogenous and Total Equivalent Concentration Exposures. Int. J. Environ. Res. Public Health 2021, 18, 607. https://doi.org/10.3390/ijerph18020607 | |
[240] | Texas Commission on Environmental Quality (TCEQ). Ethylene Oxide Carcinogenic Dose-Response Assessment. Development Support Document. Texas Commission on Environmental Quality. Final, May 15, 2020 | |
[241] | Valdez-Flores et al. Quantitative cancer risk assessment based on NIOSH and UCC epidemiological data for workers exposed to ethylene oxide, Regulatory Toxicology and Pharmacology, Volume 56, Issue 3, 2010, Pages 312-320, ISSN 0273-2300. https://doi.org/10.1016/j.yrtph.2009.10.001 | |
[242] | Valdez-Flores, C., Sielken, R.L. & Jane Teta, M. Quantitative cancer risk assessment for ethylene oxide inhalation in occupational settings. Arch Toxicol 85, 1189–1193 (2011). https://doi.org/10.1007/s00204-011-0669-2 | |
[243] | Vincent et al. Ethylene Oxide: Cancer Evidence Integration and Dose–Response Implications (2019) Dose-Response, 17 (4) DOI: 10.1177/1559325819888317 | |
[244] | US Environmental Protection Agency. (2016) Evaluation of the Inhalation Carcinogenicity of Ethylene Oxide (CASRN 75-21-8). EPA/635/R-16/350Fa. https://iris.epa.gov/static/pdfs/1025tr.pdf | |
[245] | Fryar C.D. et al. Anthropometric reference data for children and adults, Vital and health statistics. Series 3, Analytical and epidemiological studies; no. 46 : United States, 2015-2018; Published Date : January 2021. https://stacks.cdc.gov/view/cdc/100478 | |
[246] | Koch-Institut R. (2017) Reference percentiles for anthropometric measures and blood pressure based on the German Health Interview and Examination Survey for Children and Adolesce [KiGGS - Kinder- und Jugendgesundheitsstudie, 2011]. Version: 1. RKI-Bib1 (Robert Koch-Institut). https://doi.org/10.17886/RKI-GBE-2016-032 | |
[247] | The 2017 Korean National Growth Charts for children and adolescents: development, improvement, and prospects, Clin Exp Pediatr. 2018;61(5):135-149. Published online May 28, 2018. https://doi.org/10.3345/kjp.2018.61.5.135 | |
[248] | NIST Special Publication 811:2008, Guide for the Use of the International System of Units (SI) |
ICS 11.100.20 Price based on 122 pages
© ISO 2026All rights reserved
| iso.org |